ARTICLE | Regulation
White House allows FDA to release long-awaited COVID vaccine EUA guidance
CBER’s Marks: guidance aimed at increasing public confidence in FDA’s integrity
October 6, 2020 2:40 PM UTC
Updated on Oct 7, 2020 at 5:47 PM UTC
In a move that is intended to bolster public confidence in FDA’s integrity, the agency Tuesday posted guidance about emergency use authorization of COVID-19 vaccines.
FDA posted the guidance after the White House dropped a weeks-long hold it had placed on the document. The White House green light came hours after the agency had bypassed the Trump administration by releasing key provisions from the guidance in a briefing document distributed in advance of an advisory committee meeting...
BCIQ Company Profiles